Pine Pharmaceuticals is pleased to announce the promotion of Gregory Reid to Director of Production. Over the past two years, Gregory played a key role in streamlining our operations, particularly during the successful integration of Athenex's 503B business...
Company news
Looking Ahead: Exciting Growth and Opportunities for Pine Pharmaceuticals in 2025
The start of 2025 has brought exciting growth and new opportunities for Pine Pharmaceuticals, and we are looking forward to what's ahead. As we move further into the year, we are eager to continue delivering the highest level of service to facilities...
Pine Pharmaceuticals Announces the Promotion of Adam Snyder to Director of Engineering and Maintenance
Pine Pharmaceuticals is thrilled to announce the promotion of Adam Snyder to Director of Engineering and Maintenance. Over the past three years, Adam has played a pivotal role in driving innovation and operational excellence, contributing significantly to Pine's...
Exclusive Interview: Al and Alfonse Reflect on a Decade of Ownership
In continuing Pine's 10th anniversary celebration, we asked Alfonse Muto and Alfonse J. Muto, Pharm.D. ten questions about their decade-long ownership journey and Pine's remarkable evolution. Here's what they had to share: 1. How does it feel to reflect on a decade of...
Celebrating a Decade of Excellence: Pine Pharmaceuticals Marks Its 10th Anniversary
As one of the first facilities to register under section 503B, Pine Pharmaceuticals is celebrating ten years of uncompromising excellence! Founded in 2014 by father and son Alfonse Muto and Alfonse J. Muto, Pharm.D., Pine Pharmaceuticals established itself as an...
Pine Pharmaceuticals named 2023 BioPharma Business of the Year
We are thrilled to announce that Pine Pharmaceuticals has been honored as Buffalo Business First's 2023 Business of the Year in the BioPharma sector! This remarkable achievement is a testament to the unwavering dedication and tireless efforts of our entire team,...
MasterControl Award: Excellence in Analytics
We're excited to announce that Pine Pharmaceuticals has been honored with the Excellence in Analytics award by MasterControl. Spearheaded by our Innovation and Development Manager, James Ando, Pharm.D., MasterControl has been pivotal in transforming our reports into...
Pine Pharmaceuticals wins Brick by Brick Award
We're thrilled to announce that Buffalo Business First awarded Pine Pharmaceuticals a Brick by Brick award, recognizing our 50,000-square-foot expansion. These exclusive awards highlight the accomplishments of Western New York's real estate development industry. Thank...
Business First recognizes Pine Pharmaceuticals during 2023 Manufacturing Awards
We are pleased to announce that Buffalo Business First has named Pine Pharmaceuticals a 2023 Manufacturer Award winner. This award recognizes Pine as one of the top family-run businesses in the manufacturing industry and honors owners Al Sr. and Alfonse J. Muto for...
Pine Pharmaceuticals assumes Athenex’s 503B business, preserving over 50 jobs, expanding its product offerings, and serving hospitals and health systems nationwide
Tonawanda, NY, May 3, 2023 /PRNewswire/– Pine Pharmaceuticals, one of the nation's largest and most trusted FDA-registered 503B outsourcing facilities, today announced the successful integration of Athenex's 503B business, including the transfer of people, processes,...